Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$524,366
-$219,164 QoQ
Shares Held
21,776
-17.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,721
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILDRESS CAPITAL ADVISORS, LLC holds $17,780,353 across 10 Drug Manufacturers - General names. PFE ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,947 | $4,050,059 | |
| 2 | LLY |
ELI LILLY & Co
|
3,245 | $3,892,150 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,037 | $2,703,254 | |
| 4 | ABBV |
AbbVie Inc.
|
9,282 | $2,335,722 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,874 | $1,752,841 | |
| 6 | AMGN |
Amgen Inc
|
3,488 | $1,263,074 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,974 | $747,561 | |
| 8 | PFE |
Pfizer Inc
This page
|
21,776 | $524,366 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,366 | 21,776 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $743,530 | 26,479 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $653,176 | 26,232 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $685,590 | 26,907 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $402,699 | 16,613 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $483,284 | 19,072 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $363,301 | 13,694 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,300,881 | 44,951 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,285,205 | 45,933 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $469,419 | 16,916 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $582,536 | 20,234 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $656,699 | 19,798 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $202,180 | 5,512 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $265,118 | 6,498 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,057,388 | 20,636 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $812,316 | 18,563 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,008,333 | 19,232 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $904,111 | 17,464 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $881,144 | 14,922 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $744,761 | 17,316 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $520,710 | 13,297 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $480,264 | 13,256 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $277,436 | 7,537 | Shares | Sole | 2021-03-09 | |
| No filing history on record for this holder in this stock. | ||||||